Arbor Biotechnologies
Tia DiTommaso, PhD, currently serves as Senior Director of Preclinical Pharmacology at Arbor Biotechnologies, a position held since October 2019. Previously, Tia held various roles at SQZ Biotechnologies from August 2015 to August 2019, including Associate Director of Strategic Partnerships and Exploratory, Senior Scientist Project Lead, Senior Scientist, and Scientist. Tia's earlier experience includes a Postdoctoral Fellowship at Brigham and Women's Hospital/Harvard University from March 2014 to August 2015 and a PhD candidacy at Monash University from May 2009 to February 2014.
This person is not in any teams
This person is not in any offices
Arbor Biotechnologies
2 followers
Arbor Biotechnologies is an early stage life sciences company pushing the boundaries of biodiscovery. Arbor’s platform employs a diverse set of technologies and techniques – including artificial intelligence, genome sequencing, gene synthesis and high-throughput screening – for accelerating the discovery of proteins for improving human health and sustainability.